Metraipolis › archive › dc_2dc4ba97b58f

Dose-ranging and further therapeutic evaluation of a bicistronic humanized TrkB-BDNF gene therapy for glaucoma in rodents — Europe PMC PMID:40838110

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40838110
DOI
10.1186/s44477-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-10T13:00:50.323Z
SHA-256 of the archived text
975f94d2d22444303379315648d84d73ed6ab2e67cce3f02a6c9c3efbf6208e0
Stable URL of this page
https://metraipolis.com/documento/dc_2dc4ba97b58f

How to cite

Dose-ranging and further therapeutic evaluation of a bicistronic humanized TrkB-BDNF gene therapy for glaucoma in rodents — Europe PMC PMID:40838110 — Europe PMC (en), https://europepmc.org/article/MED/40838110 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2dc4ba97b58f (Metraipolis archive dc_2dc4ba97b58f, sha256 975f94d2d22444303379315648d84d73ed6ab2e67cce3f02a6c9c3efbf6208e0)
BibTeX
@misc{dc2dc4ba97b58f,
  title = {Dose-ranging and further therapeutic evaluation of a bicistronic humanized TrkB-BDNF gene therapy for glaucoma in rodents — Europe PMC PMID:40838110},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40838110},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2dc4ba97b58f; sha256 975f94d2d22444303379315648d84d73ed6ab2e67cce3f02a6c9c3efbf6208e0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40838110. Agents can read the archived copy with the MCP tool read_document.